Steven Cohen’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Steven Cohen's AUPH Position: Q3 2026 in Review
Steven Cohen opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 223,907 shares worth $3.63M. The stake represents ﹤0.01% of the portfolio and ranks #2016 among its holdings. This is a return to the name: Steven Cohen previously reported a position in AUPH as recently as Q4 2024.
Steven Cohen first reported a position in AUPH in Q4 2017 and has held it in 15 quarters since. The position peaked at $72.8M in Q4 2019. 275 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Steven Cohen held 223,907 shares of Aurinia Pharmaceuticals worth $3.63M as of Q3 2026.
- Aurinia Pharmaceuticals was a new Steven Cohen position in Q3 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2016 holding.
- Steven Cohen first reported a position in Aurinia Pharmaceuticals in Q4 2017 and has held it in 15 quarters since.
- Steven Cohen's Aurinia Pharmaceuticals position peaked at $72.8M in Q4 2019.
- 275 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.